BACKGROUND: Posttraumatic stress disorder (PTSD) and stress/trauma exposure are cross-sectionally associated with advanced DNA methylation age relative to chronological age. However, longitudinal inquiry and examination of associations between advanced DNA methylation age and a broader range of psychiatric disorders is lacking. The aim of this study was to examine if PTSD, depression, generalized anxiety, and alcohol-use disorders predicted acceleration of DNA methylation age over time (i.e. an increasing pace, or rate of advancement, of the epigenetic clock). METHODS: Genome-wide DNA methylation and a comprehensive set of psychiatric symptoms and diagnoses were assessed in 179 Iraq/Afghanistan war veterans who completed two assessments over the course of approximately 2 years. Two DNA methylation age indices (Horvath and Hannum), each a weighted index of an array of genome-wide DNA methylation probes, were quantified. The pace of the epigenetic clock was operationalized as change in DNA methylation age as a function of time between assessments. RESULTS: Analyses revealed that alcohol-use disorders (p = 0.001) and PTSD avoidance and numbing symptoms (p = 0.02) at Time 1 were associated with an increasing pace of the epigenetic clock over time, per the Horvath (but not the Hannum) index of cellular aging. CONCLUSIONS: This is the first study to suggest that posttraumatic psychopathology is longitudinally associated with a quickened pace of the epigenetic clock. Results raise the possibility that accelerated cellular aging is a common biological consequence of stress-related psychopathology, which carries implications for identifying mechanisms of stress-related cellular aging and developing interventions to slow its pace.
BACKGROUND:Posttraumatic stress disorder (PTSD) and stress/trauma exposure are cross-sectionally associated with advanced DNA methylation age relative to chronological age. However, longitudinal inquiry and examination of associations between advanced DNA methylation age and a broader range of psychiatric disorders is lacking. The aim of this study was to examine if PTSD, depression, generalized anxiety, and alcohol-use disorders predicted acceleration of DNA methylation age over time (i.e. an increasing pace, or rate of advancement, of the epigenetic clock). METHODS: Genome-wide DNA methylation and a comprehensive set of psychiatric symptoms and diagnoses were assessed in 179 Iraq/Afghanistan war veterans who completed two assessments over the course of approximately 2 years. Two DNA methylation age indices (Horvath and Hannum), each a weighted index of an array of genome-wide DNA methylation probes, were quantified. The pace of the epigenetic clock was operationalized as change in DNA methylation age as a function of time between assessments. RESULTS: Analyses revealed that alcohol-use disorders (p = 0.001) and PTSD avoidance and numbing symptoms (p = 0.02) at Time 1 were associated with an increasing pace of the epigenetic clock over time, per the Horvath (but not the Hannum) index of cellular aging. CONCLUSIONS: This is the first study to suggest that posttraumatic psychopathology is longitudinally associated with a quickened pace of the epigenetic clock. Results raise the possibility that accelerated cellular aging is a common biological consequence of stress-related psychopathology, which carries implications for identifying mechanisms of stress-related cellular aging and developing interventions to slow its pace.
Entities:
Keywords:
Alcohol-use disorders; DNA methylation age; Epigenetic age; PTSD; longitudinal
Authors: Marco P Boks; Hans C van Mierlo; Bart P F Rutten; Timothy R D J Radstake; Lot De Witte; Elbert Geuze; Steve Horvath; Leonard C Schalkwyk; Christiaan H Vinkers; Jasper C A Broen; Eric Vermetten Journal: Psychoneuroendocrinology Date: 2014-07-23 Impact factor: 4.905
Authors: Alexander Glahn; Rafael Riera Knorrenschild; Mathias Rhein; Mani Haschemi Nassab; Michael Gröschl; Annemarie Heberlein; Marc Muschler; Helge Frieling; Stefan Bleich; Thomas Hillemacher Journal: Eur Addict Res Date: 2013-12-13 Impact factor: 3.015
Authors: R T Cook; Z K Ballas; T J Waldschmidt; D Vandersteen; D R LaBrecque; B L Cook Journal: Alcohol Clin Exp Res Date: 1995-06 Impact factor: 3.455
Authors: Regina E McGlinchey; William P Milberg; Jennifer R Fonda; Catherine Brawn Fortier Journal: Int J Methods Psychiatr Res Date: 2017-02-17 Impact factor: 4.035
Authors: Filomene G Morrison; Mark W Miller; Mark W Logue; Michele Assef; Erika J Wolf Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2018-11-30 Impact factor: 5.067
Authors: May A Beydoun; Sharmin Hossain; Kumaraswamy Naidu Chitrala; Salman M Tajuddin; Hind A Beydoun; Michele K Evans; Alan B Zonderman Journal: J Affect Disord Date: 2019-06-30 Impact factor: 4.839
Authors: Erika J Wolf; Mark W Logue; Xiang Zhao; Nikolaos P Daskalakis; Filomene G Morrison; Shaline Escarfulleri; Annjanette Stone; Steven A Schichman; Regina E McGlinchey; William P Milberg; Cidi Chen; Carmela R Abraham; Mark W Miller Journal: Psychoneuroendocrinology Date: 2020-04-13 Impact factor: 4.905
Authors: Erika J Wolf; Filomene G Morrison; Danielle R Sullivan; Mark W Logue; Rachel E Guetta; Annjanette Stone; Steven A Schichman; Regina E McGlinchey; William P Milberg; Mark W Miller Journal: Brain Behav Immun Date: 2019-03-11 Impact factor: 7.217
Authors: Albert T Higgins-Chen; Marco P Boks; Christiaan H Vinkers; René S Kahn; Morgan E Levine Journal: Biol Psychiatry Date: 2020-02-08 Impact factor: 13.382
Authors: Erika J Wolf; Ci-Di Chen; Xiang Zhao; Zhenwei Zhou; Filomene G Morrison; Nikolaos P Daskalakis; Annjanette Stone; Steven Schichman; Jaclyn Garza Grenier; Dana Fein-Schaffer; Bertrand R Huber; Carmela R Abraham; Mark W Miller; Mark W Logue Journal: Neuropsychopharmacology Date: 2020-10-23 Impact factor: 7.853